Patent details
EP4069197 Title: CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCE
Basic Information
- Publication number:
- EP4069197
- PCT Application Number:
- EP2020084754
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP208173542
- PCT Publication Number:
- WO2021110983
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCE
- French Title of Invention:
- FORMES CO-AMORPHES DE BÊTA-LACTOGLOBULINE ET D'UNE SUBSTANCE MÉDICAMENTEUSE
- German Title of Invention:
- CO-AMORPHE FORMEN VON BETA-LACTOGLOBULIN UND EINER ARZNEIMITTELSUBSTANZ
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 28/06/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 04/07/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 29/05/2024
- Unitary Effect Registration Date:
- 04/07/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 04/12/2020
- Grant date:
- 29/05/2024
- EP Publication Date:
- 12/10/2022
- PCT Publication Date:
- 10/06/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/05/2024
- EP B1 Publication Date:
- 29/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 04/12/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/05/2024
- Name:
- Zerion Pharma Aps
- Address:
- Blokken 11, st., 3460 Birkerød, Denmark (DK)
Inventor
1
- Name:
- LENG, Donglei
- Address:
- Denmark (DK)
2
- Name:
- LÖBMANN, Korbinian
- Address:
- Denmark (DK)
3
- Name:
- WIBORG, Ole
- Address:
- Denmark (DK)
Priority
- Priority Number:
- 19213832
- Priority Date:
- 05/12/2019
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
Publication
European Patent Bulletin
1
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202427
- Publication date:
- 03/07/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|